D68.318 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

Billable ICD-10-CM code, FY2026. Acts as a Complication or Comorbidity (CC) as a secondary diagnosis.

Applicable to

• Antithromboplastinemia
• Antithromboplastinogenemia
• Hemorrhagic disorder due to intrinsic increase in antithrombin
• Hemorrhagic disorder due to intrinsic increase in anti-VIIIa
• Hemorrhagic disorder due to intrinsic increase in anti-IXa
• Hemorrhagic disorder due to intrinsic increase in anti-XIa

Applies from D68 Other coagulation defects

Excludes1 (never code together)

• abnormal coagulation profile NOS (R79.1)

Excludes2 (not included here)

• coagulation defects complicating abortion or ectopic or molar pregnancy (O00-O07, O08.1)
• coagulation defects complicating pregnancy, childbirth and the puerperium (O45.0, O46.0, O67.0, O72.3)

Risk adjustment (HCC)

• CMS-HCC V22: HCC 48 — Coagulation Defects and Other Specified Hematological Disorders
• ESRD V24: HCC 48

MS-DRG index

Defines the logic of DRG(s) 813 in MDC 16.

Approximate ICD-9-CM (GEMs)

• 286.59 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

Code annotations containing back-references to D68.318

Back-references to D68

• Type 1 Excludes: R79.1 Abnormal coagulation profile ("coagulation defects (D68.-)")

Diagnosis Index entries for D68.318

• Anticoagulant, circulating (intrinsic)
• Antithromboplastinemia
• Antithromboplastinogenemia
• Circulating anticoagulants
• Disorder (of) › hemorrhagic NEC › due to › intrinsic › circulating anticoagulants
• Disorder (of) › hemorrhagic NEC › due to › intrinsic › increase in › antithrombin
• Disorder (of) › hemorrhagic NEC › due to › intrinsic › increase in › anti-VIIIa
• Disorder (of) › hemorrhagic NEC › due to › intrinsic › increase in › anti-IXa
• Disorder (of) › hemorrhagic NEC › due to › intrinsic › increase in › anti-XIa

Nearby codes

• D68.2 Hereditary deficiency of other clotting factors
• D68.3 Hemorrhagic disorder due to circulating anticoagulants
• D68.31 Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
• D68.311 Acquired hemophilia
• D68.312 Antiphospholipid antibody with hemorrhagic disorder
• D68.318 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors (this code)
• D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants
• D68.4 Acquired coagulation factor deficiency
• D68.5 Primary thrombophilia
• D68.51 Activated protein C resistance
• D68.52 Prothrombin gene mutation